ArticleAlzheimer's & dementia (Amsterdam, Netherlands)

Amyloid-negative neuropsychological norms: Added value in the era of biomarkers and disease-modifying therapies.

Sara Rubio-Guerra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.